Dr. Angela Jain, MD
Claim this profileFox Chase Cancer Center
Studies Endometrial Cancer
Studies Breast Cancer
10 reported clinical trials
38 drugs studied
Area of expertise
1Endometrial Cancer
Stage IV
Stage III
HER2 positive
2Breast Cancer
HER2 positive
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Angela Jain, MD is currently running
EU101
for Solid Cancers
Phase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of EU101 in participants with advanced solid tumors. Phase 2 (Dose Expansion) of the study will assess the antitumor effect of EU101 in two indications including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).
Recruiting1 award Phase 1 & 210 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
More about Angela Jain, MD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Angela Jain, MD has experience with
- Paclitaxel
- Carboplatin
- Trastuzumab
- Pertuzumab
- Selumetinib Sulfate
- Olaparib
Breakdown of trials Angela Jain, MD has run
Endometrial Cancer
Breast Cancer
Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Angela Jain, MD specialize in?
Angela Jain, MD focuses on Endometrial Cancer and Breast Cancer. In particular, much of their work with Endometrial Cancer has involved Stage IV patients, or patients who are Stage III.
Is Angela Jain, MD currently recruiting for clinical trials?
Yes, Angela Jain, MD is currently recruiting for 6 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Angela Jain, MD has studied deeply?
Yes, Angela Jain, MD has studied treatments such as Paclitaxel, Carboplatin, Trastuzumab.
What is the best way to schedule an appointment with Angela Jain, MD?
Apply for one of the trials that Angela Jain, MD is conducting.
What is the office address of Angela Jain, MD?
The office of Angela Jain, MD is located at: Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 United States. This is the address for their practice at the Fox Chase Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.